India announces first indigenous H5N1 poultry vaccine ahead of national dedication
Published · Updated
What happened
ICAR-NIHSAD developed an indigenous vaccine for poultry against H5N1 avian influenza clade 2.3.2.1a, and its public launch was announced for 2026-11-20. The announcement comes after recent H5N1 outbreaks reported in parts of Tamil Nadu and Andhra Pradesh.
Why it matters
A domestically developed poultry H5N1 vaccine gives India a new disease-control tool that could reduce outbreak losses in the poultry sector if it is approved, produced, and adopted at scale. It also matters for animal-health preparedness, because avian influenza outbreaks can disrupt food supply chains, state compensation burdens, and export credibility.
India has announced development of its first indigenous H5N1 avian influenza vaccine for poultry, created by ICAR-NIHSAD in Bhopal and targeting the H5N1 clade 2.3.2.1a strain. The vaccine is set to be dedicated to the nation on 2026-11-20, following recent bird flu outbreaks in Tamil Nadu and Andhra Pradesh. The near-term policy question is whether authorities can move from announcement to validated production, procurement, and field deployment fast enough to reduce culling and trade disruption risks.
Watch for
ICAR or ICAR-NIHSAD release on 2026-11-20 confirming the dedication event and specifying vaccine efficacy, dosage, and target poultry species Department of Animal Husbandry and Dairying notification by 2026-11-22 on emergency use, field deployment protocol, or procurement pathway for the H5N1 vaccine Tamil Nadu Animal Husbandry Department acknowledgement by 2026-11-22 of whether the new vaccine will be used in outbreak-control zones or if culling-only rules remain in force Andhra Pradesh Animal Husbandry Department outbreak update by 2026-11-22 showing whether fresh H5N1 detections are expanding, stable, or absent after the vaccine announcement
Sources
Researched and written by AI from the sources listed, under published rules. How V³ Aware is made